YJD-61317-12315
2 vaccinations
2 coded responses
18 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 210 / MD
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-03-15
Dose 1 — Moderna
-
2021-03-19
Registered in v-safe
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-29
- 2021-04-05
-
2021-04-12
Dose 2 — Moderna
- 2021-04-12
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
- 2021-04-19
- 2021-04-26
- 2021-05-04
- 2021-05-10
- 2021-05-17
-
2021-05-24
Survey response — day 42, dose 2MedDRA: Diarrhoea, Fatigue, Headache — Feeling: FairFree text: Diahrrea headache fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-12
Survey response — 3 months, dose 2MedDRA: Dehydration — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Abnormal Dehydration and overheatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-12
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-07-14
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-10-13
- 2022-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Moderna | |
| 2 | 2021-04-12 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-07-12 | Successful 2021-07-14 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 8 — day 42, dose 2
Symptoms: Diahrrea headache fatigue
Release 9 — 3 months, dose 2
Symptoms: Abnormal Dehydration and overheating
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dehydration | ✓ | ✓ | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release